INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INMB INmune Bio Inc

交易中 07-10 14:27:39 EDT

2.26

-0.10

-4.27%

最高2.39	最低2.25	成交量144.72万
今开2.33	昨收2.36	日振幅6.14%
总市值6,006万	流通市值4,558万	总股本2,659万
成交额331.97万	换手率7.17%	流通股本2,018万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INMB","market":"US","secType":"STK","nameCN":"INmune Bio Inc","latestPrice":2.2592,"timestamp":1752172039556,"preClose":2.36,"halted":0,"volume":1447230,"delay":0,"floatShares":20177391,"shares":26585300,"eps":-1.936972,"marketStatus":"交易中","change":-0.1008,"latestTime":"07-10 14:27:39 EDT","open":2.33,"high":2.39,"low":2.245,"amount":3319691.920581,"amplitude":0.061441,"askPrice":2.26,"askSize":1488,"bidPrice":2.25,"bidSize":763,"shortable":3,"etf":0,"ttmEps":-1.936972,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752177600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1549256400000,"exchange":"NASDAQ","adjPreClose":2.36,"preHourTrading":{"tag":"盘前","latestPrice":2.33,"preClose":2.36,"latestTime":"09:28 EDT","volume":27586,"amount":64475.79229,"timestamp":1752154080075},"postHourTrading":{"tag":"盘后","latestPrice":2.33,"preClose":2.36,"latestTime":"19:56 EDT","volume":31658,"amount":73934.0047,"timestamp":1752105409523},"volumeRatio":0.536327,"impliedVol":3.6231,"impliedVolPercentile":0.916},"requestUrl":"/m/hq/s/INMB","defaultTab":"news","newsList":[{"id":"2550696605","title":"Inmune Bio Inc.7月9日成交额为463.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550696605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550696605?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:50","pubTimestamp":1752115813,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Inmune Bio Inc.成交额为463.76万美元，成交额较昨日增加12.98%，当日成交量为195.84万股。Inmune Bio Inc.于2025年7月9日涨2.61%，报2.36美元，该股过去5个交易日涨12.92%，年初至今跌49.46%，过去60日跌64.93%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-09|463.76万|12.98%|195.84万|#|2025-07-08|410.49万|-46.81%|176.56万|#|2025-07-07|771.69万|-37.21%|330.68万|#|2025-07-03|1228.91万|-8.15%|470.00万|#|2025-07-02|1337.90万|-26.27%|592.66万|INmune Bio Inc 是一家临床阶段的生物技术公司。该公司的管道产品包括 INKmune、INBO3、XPro1595、LIVNate 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710105024a44187b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710105024a44187b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2550069185","title":"Inmune Bio Inc.7月8日成交额为410.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550069185?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:49","pubTimestamp":1752029344,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Inmune Bio Inc.成交额为410.49万美元，成交额较昨日减少46.81%，当日成交量为176.56万股。Inmune Bio Inc.于2025年7月8日涨0.0%，报2.3美元，该股过去5个交易日跌0.43%，年初至今跌50.75%，过去60日跌69.86%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|410.49万|-46.81%|176.56万|#|2025-07-07|771.69万|-37.21%|330.68万|#|2025-07-03|1228.91万|-8.15%|470.00万|#|2025-07-02|1337.90万|-26.27%|592.66万|#|2025-07-01|1814.59万|-74.59%|881.19万|INmune Bio Inc 是一家临床阶段的生物技术公司。该公司的管道产品包括 INKmune、INBO3、XPro1595、LIVNate 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709104912a43f3db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709104912a43f3db8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2549593355","title":"Inmune Bio Inc.7月7日成交额为771.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549593355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549593355?lang=zh_cn&edition=full","pubTime":"2025-07-08 10:47","pubTimestamp":1751942827,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Inmune Bio Inc.成交额为771.69万美元，成交额较昨日减少37.21%，当日成交量为330.68万股。Inmune Bio Inc.于2025年7月7日跌9.09%，报2.3美元，该股过去5个交易日跌56.85%，年初至今跌50.75%，过去60日跌66.37%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-07|771.69万|-37.21%|330.68万|#|2025-07-03|1228.91万|-8.15%|470.00万|#|2025-07-02|1337.90万|-26.27%|592.66万|#|2025-07-01|1814.59万|-74.59%|881.19万|#|2025-06-30|7141.75万|-85.64%|3295.21万|INmune Bio Inc 是一家临床阶段的生物技术公司。该公司的管道产品包括 INKmune、INBO3、XPro1595、LIVNate 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708104713a69c1ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708104713a69c1ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2548433025","title":"Inmune Bio Inc.7月3日成交额为1228.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548433025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548433025?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:50","pubTimestamp":1751597411,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Inmune Bio Inc.成交额为1228.91万美元，成交额较昨日减少8.15%，当日成交量为470.00万股。Inmune Bio Inc.于2025年7月3日涨7.2%，报2.53美元，该股过去5个交易日跌59.71%，年初至今跌45.82%，过去60日跌65.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|1228.91万|-8.15%|470.00万|#|2025-07-02|1337.90万|-26.27%|592.66万|#|2025-07-01|1814.59万|-74.59%|881.19万|#|2025-06-30|7141.75万|-85.64%|3295.21万|#|2025-06-27|4.97亿|1279.23%|5989.09万|INmune Bio Inc 是一家临床阶段的生物技术公司。该公司的管道产品包括 INKmune、INBO3、XPro1595、LIVNate 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704105017a72dd6c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704105017a72dd6c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":1},{"id":"2547988097","title":"Inmune Bio Inc.盘中异动 快速跳水62.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547988097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547988097?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290283,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分，Inmune Bio Inc.股票出现异动，股价大幅跳水62.10%。截至发稿，该股报2.02美元/股，成交量1352.15万股，换手率57.83%，振幅0.84%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2015.80%、110.82%、58.41%，振幅较大的相关个股有Artelo Biosciences, Inc.、Relmada Therapeutics, Inc.、Generation Bio Co.，振幅分别为9.67%、6.56%、6.29%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213123a7264299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213123a7264299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":1},{"id":"2546741816","title":"Inmune Bio Inc.股价拉升41.16% 市值涨8530.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546741816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546741816?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:31","pubTimestamp":1751031117,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日21时31分，Inmune Bio Inc.股票出现波动，股价急速上涨41.16%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Inmune Bio Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Hcw Biologics Inc.、Inmune Bio Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为121.27%、47.05%、33.17%，振幅较大的相关个股有天境生物、Inmune Bio Inc.、Vor Biopharma Inc.，振幅分别为14.36%、9.26%、9.02%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627213158a721041b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627213158a721041b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2546774997","title":"【INmune Bio(INMB.US)盘前暴涨！将于下周公布候选药物XPro治疗早期阿尔茨海默症试验初步数据】智通财经","url":"https://stock-news.laohu8.com/highlight/detail?id=2546774997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546774997?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:28","pubTimestamp":1751030934,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a486ea388a918518e6d65c5191bc0e0d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2546133749","title":"INmune Bio(INMB.US)盘前暴涨！将于下周公布候选药物XPro治疗早期阿尔茨海默症试验初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2546133749","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546133749?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:28","pubTimestamp":1751030934,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物技术公司INmune Bio表示，将于美东时间6月30日上午8点召开电话会议，公布旗下候选药物XPro治疗早期阿尔茨海默症的MINDFuL二期试验的初步数据。市场对这一消息给予了积极回应。截至发稿，INmune Bio周五美股盘初暴涨超56%。MINDFuL试验已招募208名被诊断为轻度认知障碍或轻度AD的患者，平均年龄为72岁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"INmune Bio(INMB.US)盘前暴涨！将于下周公布候选药物XPro治疗早期阿尔茨海默症试验初步数据","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2545382612","title":"Inmune Bio Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545382612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545382612?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:43","pubTimestamp":1750772597,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时43分，Inmune Bio Inc.股票出现波动，股价快速拉升5.14%。截至发稿，该股报6.54美元/股，成交量5.801万股，换手率0.25%，振幅0.64%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242143179529a9b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242143179529a9b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","INMB","BK4139"],"gpt_icon":0},{"id":"2544179574","title":"Inmune Bio Inc.盘中异动 股价大跌5.19%报6.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544179574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544179574?lang=zh_cn&edition=full","pubTime":"2025-06-20 23:10","pubTimestamp":1750432201,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日23时10分，Inmune Bio Inc.股票出现波动，股价大幅下跌5.19%。截至发稿，该股报6.86美元/股，成交量32.6709万股，换手率1.40%，振幅8.29%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620231001a4b4e2d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620231001a4b4e2d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2544967499","title":"Inmune Bio Inc.盘中异动 急速下挫5.11%报7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544967499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544967499?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:05","pubTimestamp":1750172753,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日23时05分，Inmune Bio Inc.股票出现异动，股价急速跳水5.11%。截至发稿，该股报7.61美元/股，成交量20.7553万股，换手率0.89%，振幅5.30%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061723055397838ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061723055397838ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2542375531","title":"Inmune Bio Inc.盘中异动 下午盘急速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542375531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542375531?lang=zh_cn&edition=full","pubTime":"2025-06-12 01:10","pubTimestamp":1749661805,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日01时10分，Inmune Bio Inc.股票出现异动，股价快速上涨5.20%。截至发稿，该股报8.29美元/股，成交量42.532万股，换手率1.83%，振幅5.77%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Kazia Therapeutics Limited、Synaptogenix, Inc.、Vaxart, Inc. - Common Stock涨幅较大，Nucana Plc、Kazia Therapeutics Limited、Windtree Therapeutics, Inc.较为活跃，换手率分别为11132.22%、3165.53%、196.79%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kazia Therapeutics Limited，振幅分别为88.67%、84.50%、79.16%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612011005a4a3cac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612011005a4a3cac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2542483273","title":"Inmune Bio Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542483273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542483273?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:50","pubTimestamp":1749563439,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时50分，Inmune Bio Inc.股票出现异动，股价大幅上涨5.36%。截至发稿，该股报8.06美元/股，成交量5.4954万股，换手率0.24%，振幅3.53%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc、Evogene Ltd.涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为12995.83%、1746.61%、977.07%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为130.69%、99.74%、53.16%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610215039a7023e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610215039a7023e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2542380148","title":"Inmune Bio Inc.盘中异动 早盘股价大涨5.38%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380148?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:39","pubTimestamp":1749476361,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时39分，Inmune Bio Inc.股票出现异动，股价急速上涨5.38%。截至发稿，该股报8.03美元/股，成交量2.4986万股，换手率0.11%，振幅4.00%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213921a700b19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213921a700b19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2541786354","title":"Inmune Bio Inc.盘中异动 大幅拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541786354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541786354?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:36","pubTimestamp":1749216997,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时36分，Inmune Bio Inc.股票出现波动，股价快速上涨5.31%。截至发稿，该股报7.74美元/股，成交量1.3326万股，换手率0.06%，振幅4.49%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Eyenovia, Inc.、Nucana Plc、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为1349.67%、532.49%、75.23%，振幅较大的相关个股有Silo Pharma, Inc.、Eyenovia, Inc.、Nucana Plc，振幅分别为26.33%、22.29%、16.71%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621363795116cc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621363795116cc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2538622664","title":"Inmune Bio Inc.盘中异动 早盘股价大涨5.82%报7.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538622664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538622664?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:08","pubTimestamp":1748354922,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时08分，Inmune Bio Inc.股票出现波动，股价快速拉升5.82%。截至发稿，该股报7.73美元/股，成交量5.0314万股，换手率0.22%，振幅2.44%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220843976746e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220843976746e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2536158297","title":"Inmune Bio Inc.2025财年第一财季实现净利润-9.74百万美元，同比增加11.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536158297","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536158297?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497659,"startTime":"0","endTime":"0","summary":"5月18日，Inmune Bio Inc.公布财报，公告显示公司2025财年第一财季净利润为-9.74百万美元，同比增加11.70%；其中营业收入为50000.00美元，同比增加257.14%，每股基本收益为-0.43美元。从资产负债表来看，Inmune Bio Inc.总负债8.13百万美元，其中短期债务146000.00美元，资产负债比为4.65，流动比率为2.65。机构评级：截至2025年5月18日，当前有5家机构对Inmune Bio Inc.目标价做出预测，其中目标均价为23.40美元，其中最低目标价为20.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000616a4821f3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000616a4821f3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB"],"gpt_icon":0},{"id":"2535076662","title":"Inmune Bio Inc.盘中异动 快速下跌5.65%报7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535076662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535076662?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:26","pubTimestamp":1747232794,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时26分，Inmune Bio Inc.股票出现异动，股价快速跳水5.65%。截至发稿，该股报7.61美元/股，成交量2.9255万股，换手率0.13%，振幅6.20%。Inmune Bio Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Klotho Neurosciences, Inc.、Onconetix, Inc.、蓝鸟生物涨幅较大，Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3358.88%、2765.38%、1450.62%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Onconetix, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为330.31%、112.50%、74.57%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514222634a6df15ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514222634a6df15ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2534794032","title":"Inmune Bio Inc.盘中异动 早盘股价大涨5.60%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534794032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534794032?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:45","pubTimestamp":1747057509,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时45分，Inmune Bio Inc.股票出现波动，股价大幅上涨5.60%。截至发稿，该股报7.36美元/股，成交量4.2152万股，换手率0.18%，振幅2.73%。Inmune Bio Inc.股票所在的生物技术行业中，整体涨幅为2.96%。Inmune Bio Inc.公司简介：INmune Bio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214509aa2c8b4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214509aa2c8b4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2534162109","title":"INmune Bio(INMB.US)：2025年Q1财报实现营收5万美元，前值为1.4万美元；每股收益为-0.43美元，前值为-0.61美元，预期值为-0.46美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534162109","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534162109?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:56","pubTimestamp":1746737808,"startTime":"0","endTime":"0","summary":"INmune Bio(INMB.US)：2025年Q1财报实现营收5万美元，前值为1.4万美元；每股收益为-0.43美元，前值为-0.61美元，预期值为-0.46美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09045650243081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INMB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inmunebio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.6915},{"period":"3month","weight":-0.6493},{"period":"6month","weight":-0.5701},{"period":"1year","weight":-0.6974},{"period":"ytd","weight":-0.4946}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"INmune Bio Inc.最初于2015年9月25日在内华达州成立。公司的目标是开发和商业化产品，治疗先天免疫系统无法正常工作或者由此导致的疾病。这些疾病包括癌症，其中NK细胞缺少活性导致肿瘤能逃避免疫系统，MDSC增殖以保护肿瘤免受患者免疫系统的攻击，也包括类似功能障碍或其他神经和代谢疾病的引起的慢性感染，慢性炎症引起免疫系统功能障碍进而导致的代谢疾病。INmune Bio Inc.最初的重点是治疗癌症 - 血液系统恶性肿瘤和实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.247906},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.078582},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.130079},{"month":4,"riseRate":0.714286,"avgChangeRate":0.129038},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.009646},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.015231},{"month":7,"riseRate":0.428571,"avgChangeRate":0.137413},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.04324},{"month":9,"riseRate":0,"avgChangeRate":-0.132961},{"month":10,"riseRate":0.5,"avgChangeRate":-0.013151},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.009673},{"month":12,"riseRate":0.5,"avgChangeRate":0.154488}],"exchange":"NASDAQ","name":"INmune Bio Inc","nameEN":"INmune Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供INmune Bio Inc(INMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"INmune Bio Inc,INMB,INmune Bio Inc股票,INmune Bio Inc股票老虎,INmune Bio Inc股票老虎国际,INmune Bio Inc行情,INmune Bio Inc股票行情,INmune Bio Inc股价,INmune Bio Inc股市,INmune Bio Inc股票价格,INmune Bio Inc股票交易,INmune Bio Inc股票购买,INmune Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INmune Bio Inc(INMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供INmune Bio Inc(INMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}